Spearhead Opens Applications for $1M Angel Funds

Founders can also apply for a $10M fund when they graduate

Today, we’re opening applications for the third class of Spearhead—where founders get their own funds, so they can learn the craft of angel investing.

Founders backing founders

We’re getting bigger in this class: Founders now get $1M angel funds and can also apply for a $10M fund at the end of the program.

We’re targeting current or past founders in four locations: Silicon Valley, Los Angeles, New York City and Boston. We’re especially interested in technical founders in the markets listed at the bottom of this post.

Angel investing experience is not required. We will teach you how to invest and give you access to mentors like Keith Rabois, Cyan Banister, David Sacks, Elad Gil and Mike Maples.

Two classes, 160 investments so far

We accepted a total of 38 founders in the first two classes. They came from companies including PillPack, OpenDoor, Neuralink, Shippo, Rippling and Scale. Together, these companies are worth over $10B—four of the companies are unicorns, and half of them are worth more than $100M.

With their new capital and know-how, founders in the first two classes have invested $8M in 160 companies alongside Sam Altman, First Round Capital, A16Z, Khosla, Floodgate, Founders Fund and many others.

From founding startups to investing in them

Startups want to raise money from founders because they offer great advice, have great networks and know their markets better than anyone. 

Angel investing should be accessible to anyone who wants to put in the work, not just people with money and connections. We see entrepreneurship as a career that goes from founding startups to investing in them. Apply now.

Learn more on TechCrunch.

Markets

  • Agriculture and Food Tech
  • AR and VR
  • Autonomy and Robotics
  • Crypto
  • Cybersecurity
  • Deep Tech (Quantum, Space, Drones, 3D printing, etc.)
  • Fintech 
  • Hardware 
  • Healthcare
  • Infrastructure Software 
  • Machine Learning and AI 
  • SaaS
  • Synthetic Biology